Cargando…
Analysis of the Effectiveness and Cost Benefit of Leukotriene Modifiers in Adults With Asthma in the Ohio Medicaid Population
OBJECTIVES: The objectives of this research were to (1) determine the association of the use of leukotriene modifiers (LMs) with 3 clinical outcome measures that can serve as proxy measures of effectiveness: subsequent emergency room visits, hospitalizations, and steroid bursts, and (2) estimate whe...
Autores principales: | Heaton, Pamela C., Guo, Jeff J., Hornung, Richard W., Johnston, Joseph A., Jang, Raymond, Moomaw, Charles J., Cluxton Jr., Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437319/ https://www.ncbi.nlm.nih.gov/pubmed/16420106 http://dx.doi.org/10.18553/jmcp.2006.12.1.33 |
Ejemplares similares
-
Role of Leukotrienes and Leukotriene Modifiers in Asthma
por: Montuschi, Paolo
Publicado: (2010) -
Genome-wide association study of leukotriene modifier response in asthma
por: Dahlin, A, et al.
Publicado: (2016) -
Adipokines and Cysteinyl Leukotrienes in the Pathogenesis of Asthma
por: Coffey, Michael J., et al.
Publicado: (2015) -
End-of-Life Expenditures by Ohio Medicaid Beneficiaries Dying of Cancer
por: Koroukian, Siran M., et al.
Publicado: (2006) -
EVALUATING EXPENDITURES AND UTILIZATION OF OHIO'S INTEGRATED MEDICARE AND MEDICAID PROGRAM
por: Bowblis, John, et al.
Publicado: (2022)